Global Clinical Trial Imaging Market Growth (Status and Outlook) 2025-2031

Product Code: 1286220

Industry: Service & Software

Published: Jul 05,2025

Pages: 132

Delivery Time: 2-3 business days

Global Clinical Trial Imaging Market Growth (Status and Outlook) 2025-2031

Product Code: 1286220

Industry: Service & Software

Published: Jul 05,2025

Pages: 132

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global Clinical Trial Imaging market size will reach US$ 2482 million by 2031.

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.

The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.

Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

The driving factors of the clinical trial imaging market mainly include the following:
Technological progress: innovation drives core growth
High-precision and multimodal imaging technology
Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.

Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.

Artificial Intelligence and Automation
AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.

Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.

Portable and Real-time Imaging
Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.

Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.

Policy support: Create a favorable development environment
Improvement of regulatory framework
FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.

International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.

Funding and Incentives
Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.

Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.

Growth in medical demand: changes in population and disease structure
Aging and chronic disease burden
High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.

Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).

New drug development and clinical trial expansion
Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.

Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.

The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.

LPI (LP Information)' newest research report, the “Clinical Trial Imaging Industry Forecast” looks at past sales and reviews total world Clinical Trial Imaging sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Trial Imaging sales for 2025 through 2031. With Clinical Trial Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Imaging industry.

This Insight Report provides a comprehensive analysis of the global Clinical Trial Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Trial Imaging market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Imaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Imaging.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Imaging market by product type, application, key players and key regions and countries.

Segmentation by Type:
    In-house Imaging Service
    Central Imaging Service

Segmentation by Application:
    Pharmaceutical Companies
    Biotechnology Companies
    Academic Institutes
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    ICON
    ERT
    McLaren
    Bioclinica
    Parexel
    BioTelemetry
    ProScan Imaging
    Imaging Endpoints
    Radiant Sage
    Micron, Inc.
    Intrinsic Imaging
    Median Technologies
    Cardiovascular Imaging Technologies
    Banook Medical
    IXICO
    Tigermed
    Runda Medical
    Konica Minolta
    Keosys

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Clinical Trial Imaging Market Size (2020-2031)
        2.1.2 Clinical Trial Imaging Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Clinical Trial Imaging by Country/Region (2020, 2024 & 2031)
    2.2 Clinical Trial Imaging Segment by Type
        2.2.1 In-house Imaging Service
        2.2.2 Central Imaging Service
    2.3 Clinical Trial Imaging Market Size by Type
        2.3.1 Clinical Trial Imaging Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Clinical Trial Imaging Market Size Market Share by Type (2020-2025)
    2.4 Clinical Trial Imaging Segment by Application
        2.4.1 Pharmaceutical Companies
        2.4.2 Biotechnology Companies
        2.4.3 Academic Institutes
        2.4.4 Others
    2.5 Clinical Trial Imaging Market Size by Application
        2.5.1 Clinical Trial Imaging Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Clinical Trial Imaging Market Size Market Share by Application (2020-2025)

3 Clinical Trial Imaging Market Size by Player
    3.1 Clinical Trial Imaging Market Size Market Share by Player
        3.1.1 Global Clinical Trial Imaging Revenue by Player (2020-2025)
        3.1.2 Global Clinical Trial Imaging Revenue Market Share by Player (2020-2025)
    3.2 Global Clinical Trial Imaging Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Clinical Trial Imaging by Region
    4.1 Clinical Trial Imaging Market Size by Region (2020-2025)
    4.2 Global Clinical Trial Imaging Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Clinical Trial Imaging Market Size Growth (2020-2025)
    4.4 APAC Clinical Trial Imaging Market Size Growth (2020-2025)
    4.5 Europe Clinical Trial Imaging Market Size Growth (2020-2025)
    4.6 Middle East & Africa Clinical Trial Imaging Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Clinical Trial Imaging Market Size by Country (2020-2025)
    5.2 Americas Clinical Trial Imaging Market Size by Type (2020-2025)
    5.3 Americas Clinical Trial Imaging Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Clinical Trial Imaging Market Size by Region (2020-2025)
    6.2 APAC Clinical Trial Imaging Market Size by Type (2020-2025)
    6.3 APAC Clinical Trial Imaging Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Clinical Trial Imaging Market Size by Country (2020-2025)
    7.2 Europe Clinical Trial Imaging Market Size by Type (2020-2025)
    7.3 Europe Clinical Trial Imaging Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Clinical Trial Imaging by Region (2020-2025)
    8.2 Middle East & Africa Clinical Trial Imaging Market Size by Type (2020-2025)
    8.3 Middle East & Africa Clinical Trial Imaging Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Clinical Trial Imaging Market Forecast
    10.1 Global Clinical Trial Imaging Forecast by Region (2026-2031)
        10.1.1 Global Clinical Trial Imaging Forecast by Region (2026-2031)
        10.1.2 Americas Clinical Trial Imaging Forecast
        10.1.3 APAC Clinical Trial Imaging Forecast
        10.1.4 Europe Clinical Trial Imaging Forecast
        10.1.5 Middle East & Africa Clinical Trial Imaging Forecast
    10.2 Americas Clinical Trial Imaging Forecast by Country (2026-2031)
        10.2.1 United States Market Clinical Trial Imaging Forecast
        10.2.2 Canada Market Clinical Trial Imaging Forecast
        10.2.3 Mexico Market Clinical Trial Imaging Forecast
        10.2.4 Brazil Market Clinical Trial Imaging Forecast
    10.3 APAC Clinical Trial Imaging Forecast by Region (2026-2031)
        10.3.1 China Clinical Trial Imaging Market Forecast
        10.3.2 Japan Market Clinical Trial Imaging Forecast
        10.3.3 Korea Market Clinical Trial Imaging Forecast
        10.3.4 Southeast Asia Market Clinical Trial Imaging Forecast
        10.3.5 India Market Clinical Trial Imaging Forecast
        10.3.6 Australia Market Clinical Trial Imaging Forecast
    10.4 Europe Clinical Trial Imaging Forecast by Country (2026-2031)
        10.4.1 Germany Market Clinical Trial Imaging Forecast
        10.4.2 France Market Clinical Trial Imaging Forecast
        10.4.3 UK Market Clinical Trial Imaging Forecast
        10.4.4 Italy Market Clinical Trial Imaging Forecast
        10.4.5 Russia Market Clinical Trial Imaging Forecast
    10.5 Middle East & Africa Clinical Trial Imaging Forecast by Region (2026-2031)
        10.5.1 Egypt Market Clinical Trial Imaging Forecast
        10.5.2 South Africa Market Clinical Trial Imaging Forecast
        10.5.3 Israel Market Clinical Trial Imaging Forecast
        10.5.4 Turkey Market Clinical Trial Imaging Forecast
    10.6 Global Clinical Trial Imaging Forecast by Type (2026-2031)
    10.7 Global Clinical Trial Imaging Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Clinical Trial Imaging Forecast

11 Key Players Analysis
    11.1 ICON
        11.1.1 ICON Company Information
        11.1.2 ICON Clinical Trial Imaging Product Offered
        11.1.3 ICON Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 ICON Main Business Overview
        11.1.5 ICON Latest Developments
    11.2 ERT
        11.2.1 ERT Company Information
        11.2.2 ERT Clinical Trial Imaging Product Offered
        11.2.3 ERT Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 ERT Main Business Overview
        11.2.5 ERT Latest Developments
    11.3 McLaren
        11.3.1 McLaren Company Information
        11.3.2 McLaren Clinical Trial Imaging Product Offered
        11.3.3 McLaren Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 McLaren Main Business Overview
        11.3.5 McLaren Latest Developments
    11.4 Bioclinica
        11.4.1 Bioclinica Company Information
        11.4.2 Bioclinica Clinical Trial Imaging Product Offered
        11.4.3 Bioclinica Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Bioclinica Main Business Overview
        11.4.5 Bioclinica Latest Developments
    11.5 Parexel
        11.5.1 Parexel Company Information
        11.5.2 Parexel Clinical Trial Imaging Product Offered
        11.5.3 Parexel Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Parexel Main Business Overview
        11.5.5 Parexel Latest Developments
    11.6 BioTelemetry
        11.6.1 BioTelemetry Company Information
        11.6.2 BioTelemetry Clinical Trial Imaging Product Offered
        11.6.3 BioTelemetry Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 BioTelemetry Main Business Overview
        11.6.5 BioTelemetry Latest Developments
    11.7 ProScan Imaging
        11.7.1 ProScan Imaging Company Information
        11.7.2 ProScan Imaging Clinical Trial Imaging Product Offered
        11.7.3 ProScan Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 ProScan Imaging Main Business Overview
        11.7.5 ProScan Imaging Latest Developments
    11.8 Imaging Endpoints
        11.8.1 Imaging Endpoints Company Information
        11.8.2 Imaging Endpoints Clinical Trial Imaging Product Offered
        11.8.3 Imaging Endpoints Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Imaging Endpoints Main Business Overview
        11.8.5 Imaging Endpoints Latest Developments
    11.9 Radiant Sage
        11.9.1 Radiant Sage Company Information
        11.9.2 Radiant Sage Clinical Trial Imaging Product Offered
        11.9.3 Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Radiant Sage Main Business Overview
        11.9.5 Radiant Sage Latest Developments
    11.10 Micron, Inc.
        11.10.1 Micron, Inc. Company Information
        11.10.2 Micron, Inc. Clinical Trial Imaging Product Offered
        11.10.3 Micron, Inc. Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Micron, Inc. Main Business Overview
        11.10.5 Micron, Inc. Latest Developments
    11.11 Intrinsic Imaging
        11.11.1 Intrinsic Imaging Company Information
        11.11.2 Intrinsic Imaging Clinical Trial Imaging Product Offered
        11.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Intrinsic Imaging Main Business Overview
        11.11.5 Intrinsic Imaging Latest Developments
    11.12 Median Technologies
        11.12.1 Median Technologies Company Information
        11.12.2 Median Technologies Clinical Trial Imaging Product Offered
        11.12.3 Median Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 Median Technologies Main Business Overview
        11.12.5 Median Technologies Latest Developments
    11.13 Cardiovascular Imaging Technologies
        11.13.1 Cardiovascular Imaging Technologies Company Information
        11.13.2 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Offered
        11.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 Cardiovascular Imaging Technologies Main Business Overview
        11.13.5 Cardiovascular Imaging Technologies Latest Developments
    11.14 Banook Medical
        11.14.1 Banook Medical Company Information
        11.14.2 Banook Medical Clinical Trial Imaging Product Offered
        11.14.3 Banook Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 Banook Medical Main Business Overview
        11.14.5 Banook Medical Latest Developments
    11.15 IXICO
        11.15.1 IXICO Company Information
        11.15.2 IXICO Clinical Trial Imaging Product Offered
        11.15.3 IXICO Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.15.4 IXICO Main Business Overview
        11.15.5 IXICO Latest Developments
    11.16 Tigermed
        11.16.1 Tigermed Company Information
        11.16.2 Tigermed Clinical Trial Imaging Product Offered
        11.16.3 Tigermed Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.16.4 Tigermed Main Business Overview
        11.16.5 Tigermed Latest Developments
    11.17 Runda Medical
        11.17.1 Runda Medical Company Information
        11.17.2 Runda Medical Clinical Trial Imaging Product Offered
        11.17.3 Runda Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.17.4 Runda Medical Main Business Overview
        11.17.5 Runda Medical Latest Developments
    11.18 Konica Minolta
        11.18.1 Konica Minolta Company Information
        11.18.2 Konica Minolta Clinical Trial Imaging Product Offered
        11.18.3 Konica Minolta Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.18.4 Konica Minolta Main Business Overview
        11.18.5 Konica Minolta Latest Developments
    11.19 Keosys
        11.19.1 Keosys Company Information
        11.19.2 Keosys Clinical Trial Imaging Product Offered
        11.19.3 Keosys Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.19.4 Keosys Main Business Overview
        11.19.5 Keosys Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Clinical Trial Imaging Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Clinical Trial Imaging Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of In-house Imaging Service
 Table 4. Major Players of Central Imaging Service
 Table 5. Clinical Trial Imaging Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 6. Global Clinical Trial Imaging Market Size by Type (2020-2025) & ($ millions)
 Table 7. Global Clinical Trial Imaging Market Size Market Share by Type (2020-2025)
 Table 8. Clinical Trial Imaging Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 9. Global Clinical Trial Imaging Market Size by Application (2020-2025) & ($ millions)
 Table 10. Global Clinical Trial Imaging Market Size Market Share by Application (2020-2025)
 Table 11. Global Clinical Trial Imaging Revenue by Player (2020-2025) & ($ millions)
 Table 12. Global Clinical Trial Imaging Revenue Market Share by Player (2020-2025)
 Table 13. Clinical Trial Imaging Key Players Head office and Products Offered
 Table 14. Clinical Trial Imaging Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global Clinical Trial Imaging Market Size by Region (2020-2025) & ($ millions)
 Table 18. Global Clinical Trial Imaging Market Size Market Share by Region (2020-2025)
 Table 19. Global Clinical Trial Imaging Revenue by Country/Region (2020-2025) & ($ millions)
 Table 20. Global Clinical Trial Imaging Revenue Market Share by Country/Region (2020-2025)
 Table 21. Americas Clinical Trial Imaging Market Size by Country (2020-2025) & ($ millions)
 Table 22. Americas Clinical Trial Imaging Market Size Market Share by Country (2020-2025)
 Table 23. Americas Clinical Trial Imaging Market Size by Type (2020-2025) & ($ millions)
 Table 24. Americas Clinical Trial Imaging Market Size Market Share by Type (2020-2025)
 Table 25. Americas Clinical Trial Imaging Market Size by Application (2020-2025) & ($ millions)
 Table 26. Americas Clinical Trial Imaging Market Size Market Share by Application (2020-2025)
 Table 27. APAC Clinical Trial Imaging Market Size by Region (2020-2025) & ($ millions)
 Table 28. APAC Clinical Trial Imaging Market Size Market Share by Region (2020-2025)
 Table 29. APAC Clinical Trial Imaging Market Size by Type (2020-2025) & ($ millions)
 Table 30. APAC Clinical Trial Imaging Market Size by Application (2020-2025) & ($ millions)
 Table 31. Europe Clinical Trial Imaging Market Size by Country (2020-2025) & ($ millions)
 Table 32. Europe Clinical Trial Imaging Market Size Market Share by Country (2020-2025)
 Table 33. Europe Clinical Trial Imaging Market Size by Type (2020-2025) & ($ millions)
 Table 34. Europe Clinical Trial Imaging Market Size by Application (2020-2025) & ($ millions)
 Table 35. Middle East & Africa Clinical Trial Imaging Market Size by Region (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Clinical Trial Imaging Market Size by Type (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Clinical Trial Imaging Market Size by Application (2020-2025) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of Clinical Trial Imaging
 Table 39. Key Market Challenges & Risks of Clinical Trial Imaging
 Table 40. Key Industry Trends of Clinical Trial Imaging
 Table 41. Global Clinical Trial Imaging Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 42. Global Clinical Trial Imaging Market Size Market Share Forecast by Region (2026-2031)
 Table 43. Global Clinical Trial Imaging Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 44. Global Clinical Trial Imaging Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 45. ICON Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 46. ICON Clinical Trial Imaging Product Offered
 Table 47. ICON Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 48. ICON Main Business
 Table 49. ICON Latest Developments
 Table 50. ERT Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 51. ERT Clinical Trial Imaging Product Offered
 Table 52. ERT Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 53. ERT Main Business
 Table 54. ERT Latest Developments
 Table 55. McLaren Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 56. McLaren Clinical Trial Imaging Product Offered
 Table 57. McLaren Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 58. McLaren Main Business
 Table 59. McLaren Latest Developments
 Table 60. Bioclinica Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 61. Bioclinica Clinical Trial Imaging Product Offered
 Table 62. Bioclinica Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 63. Bioclinica Main Business
 Table 64. Bioclinica Latest Developments
 Table 65. Parexel Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 66. Parexel Clinical Trial Imaging Product Offered
 Table 67. Parexel Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 68. Parexel Main Business
 Table 69. Parexel Latest Developments
 Table 70. BioTelemetry Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 71. BioTelemetry Clinical Trial Imaging Product Offered
 Table 72. BioTelemetry Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 73. BioTelemetry Main Business
 Table 74. BioTelemetry Latest Developments
 Table 75. ProScan Imaging Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 76. ProScan Imaging Clinical Trial Imaging Product Offered
 Table 77. ProScan Imaging Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 78. ProScan Imaging Main Business
 Table 79. ProScan Imaging Latest Developments
 Table 80. Imaging Endpoints Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 81. Imaging Endpoints Clinical Trial Imaging Product Offered
 Table 82. Imaging Endpoints Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 83. Imaging Endpoints Main Business
 Table 84. Imaging Endpoints Latest Developments
 Table 85. Radiant Sage Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 86. Radiant Sage Clinical Trial Imaging Product Offered
 Table 87. Radiant Sage Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 88. Radiant Sage Main Business
 Table 89. Radiant Sage Latest Developments
 Table 90. Micron, Inc. Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 91. Micron, Inc. Clinical Trial Imaging Product Offered
 Table 92. Micron, Inc. Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 93. Micron, Inc. Main Business
 Table 94. Micron, Inc. Latest Developments
 Table 95. Intrinsic Imaging Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 96. Intrinsic Imaging Clinical Trial Imaging Product Offered
 Table 97. Intrinsic Imaging Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 98. Intrinsic Imaging Main Business
 Table 99. Intrinsic Imaging Latest Developments
 Table 100. Median Technologies Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 101. Median Technologies Clinical Trial Imaging Product Offered
 Table 102. Median Technologies Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 103. Median Technologies Main Business
 Table 104. Median Technologies Latest Developments
 Table 105. Cardiovascular Imaging Technologies Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 106. Cardiovascular Imaging Technologies Clinical Trial Imaging Product Offered
 Table 107. Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 108. Cardiovascular Imaging Technologies Main Business
 Table 109. Cardiovascular Imaging Technologies Latest Developments
 Table 110. Banook Medical Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 111. Banook Medical Clinical Trial Imaging Product Offered
 Table 112. Banook Medical Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 113. Banook Medical Main Business
 Table 114. Banook Medical Latest Developments
 Table 115. IXICO Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 116. IXICO Clinical Trial Imaging Product Offered
 Table 117. IXICO Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 118. IXICO Main Business
 Table 119. IXICO Latest Developments
 Table 120. Tigermed Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 121. Tigermed Clinical Trial Imaging Product Offered
 Table 122. Tigermed Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 123. Tigermed Main Business
 Table 124. Tigermed Latest Developments
 Table 125. Runda Medical Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 126. Runda Medical Clinical Trial Imaging Product Offered
 Table 127. Runda Medical Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 128. Runda Medical Main Business
 Table 129. Runda Medical Latest Developments
 Table 130. Konica Minolta Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 131. Konica Minolta Clinical Trial Imaging Product Offered
 Table 132. Konica Minolta Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 133. Konica Minolta Main Business
 Table 134. Konica Minolta Latest Developments
 Table 135. Keosys Details, Company Type, Clinical Trial Imaging Area Served and Its Competitors
 Table 136. Keosys Clinical Trial Imaging Product Offered
 Table 137. Keosys Clinical Trial Imaging Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 138. Keosys Main Business
 Table 139. Keosys Latest Developments


List of Figures
 Figure 1. Clinical Trial Imaging Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Clinical Trial Imaging Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Clinical Trial Imaging Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Clinical Trial Imaging Sales Market Share by Country/Region (2024)
 Figure 8. Clinical Trial Imaging Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Clinical Trial Imaging Market Size Market Share by Type in 2024
 Figure 10. Clinical Trial Imaging in Pharmaceutical Companies
 Figure 11. Global Clinical Trial Imaging Market: Pharmaceutical Companies (2020-2025) & ($ millions)
 Figure 12. Clinical Trial Imaging in Biotechnology Companies
 Figure 13. Global Clinical Trial Imaging Market: Biotechnology Companies (2020-2025) & ($ millions)
 Figure 14. Clinical Trial Imaging in Academic Institutes
 Figure 15. Global Clinical Trial Imaging Market: Academic Institutes (2020-2025) & ($ millions)
 Figure 16. Clinical Trial Imaging in Others
 Figure 17. Global Clinical Trial Imaging Market: Others (2020-2025) & ($ millions)
 Figure 18. Global Clinical Trial Imaging Market Size Market Share by Application in 2024
 Figure 19. Global Clinical Trial Imaging Revenue Market Share by Player in 2024
 Figure 20. Global Clinical Trial Imaging Market Size Market Share by Region (2020-2025)
 Figure 21. Americas Clinical Trial Imaging Market Size 2020-2025 ($ millions)
 Figure 22. APAC Clinical Trial Imaging Market Size 2020-2025 ($ millions)
 Figure 23. Europe Clinical Trial Imaging Market Size 2020-2025 ($ millions)
 Figure 24. Middle East & Africa Clinical Trial Imaging Market Size 2020-2025 ($ millions)
 Figure 25. Americas Clinical Trial Imaging Value Market Share by Country in 2024
 Figure 26. United States Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 27. Canada Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 28. Mexico Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 29. Brazil Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 30. APAC Clinical Trial Imaging Market Size Market Share by Region in 2024
 Figure 31. APAC Clinical Trial Imaging Market Size Market Share by Type (2020-2025)
 Figure 32. APAC Clinical Trial Imaging Market Size Market Share by Application (2020-2025)
 Figure 33. China Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 34. Japan Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 35. South Korea Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 36. Southeast Asia Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 37. India Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 38. Australia Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 39. Europe Clinical Trial Imaging Market Size Market Share by Country in 2024
 Figure 40. Europe Clinical Trial Imaging Market Size Market Share by Type (2020-2025)
 Figure 41. Europe Clinical Trial Imaging Market Size Market Share by Application (2020-2025)
 Figure 42. Germany Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 43. France Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 44. UK Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 45. Italy Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 46. Russia Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 47. Middle East & Africa Clinical Trial Imaging Market Size Market Share by Region (2020-2025)
 Figure 48. Middle East & Africa Clinical Trial Imaging Market Size Market Share by Type (2020-2025)
 Figure 49. Middle East & Africa Clinical Trial Imaging Market Size Market Share by Application (2020-2025)
 Figure 50. Egypt Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 51. South Africa Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 52. Israel Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 53. Turkey Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 54. GCC Countries Clinical Trial Imaging Market Size Growth 2020-2025 ($ millions)
 Figure 55. Americas Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 56. APAC Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 57. Europe Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 58. Middle East & Africa Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 59. United States Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 60. Canada Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 61. Mexico Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 62. Brazil Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 63. China Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 64. Japan Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 65. Korea Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 66. Southeast Asia Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 67. India Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 68. Australia Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 69. Germany Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 70. France Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 71. UK Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 72. Italy Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 73. Russia Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 74. Egypt Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 75. South Africa Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 76. Israel Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 77. Turkey Clinical Trial Imaging Market Size 2026-2031 ($ millions)
 Figure 78. Global Clinical Trial Imaging Market Size Market Share Forecast by Type (2026-2031)
 Figure 79. Global Clinical Trial Imaging Market Size Market Share Forecast by Application (2026-2031)
 Figure 80. GCC Countries Clinical Trial Imaging Market Size 2026-2031 ($ millions)

Companies Mentioned

ICON

ERT

McLaren

Bioclinica

Parexel

BioTelemetry

ProScan Imaging

Imaging Endpoints

Radiant Sage

Micron, Inc.

Intrinsic Imaging

Median Technologies

Cardiovascular Imaging Technologies

Banook Medical

IXICO

Tigermed

Runda Medical

Konica Minolta

Keosys

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff